MedTrace Logo

Safety Study in Retinal Transplantation for Retinitis Pigmentosa.

NCT00345917 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-04-11

No results posted yet for this study

Summary

The long-term goal is to show that retinal transplantation can help to prevent blindness and to restore eyesight in patients with the inherited disease retinitis pigmentosa.

Conditions

  • Retinitis Pigmentosa.

Interventions

DEVICE

Retinal transplantation instrument

DEVICE

Fetal tissue.

Sponsors & Collaborators

  • Foundation Fighting Blindness

    collaborator OTHER

  • Radtke, Norman D., M.D.

    lead INDIV

Principal Investigators

  • Norman D. Radtke, M.D. · Norman D. Radtke, M.D.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00345917 on ClinicalTrials.gov